Boiron
Canada-wide class action alleges Boiron misled consumers by advertising Oscillo as a flu cure despite it being a sugar placebo.
Opening soonCanada-wideDeadline: Pending court decisionEst. payout: Compensation pendingDeadline pending
About this settlement
The lawsuit alleges that Oscillo was falsely advertised as an effective flu treatment when it contains no active medicinal ingredients.
This class action challenges Boiron's advertising of Oscillococcinum as a flu cure, asserting it is a sugar placebo with no active ingredients or health benefits. The case is certified by the Quebec Court of Appeal and covers all Canadian residents who purchased Oscillo products.
Who qualifies
- Residents of Canada who purchased Oscillococcinum or Children Oscillococcinum.
- Individuals misled by the product's advertising claims.
Compensation pending
Deadline Pending court decision